Tavlesse

fostamatinib disodium · Instituto Grifols S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tavlesse, covering 2019-01-25 to 2024-12-02. Get the full timeline:

Most recent: EMA Authorised: Tavlesse (Fostamatinib disodium) — Instituto Grifols S.A.